In a cohort of critical COVID-19 patients with hypertension, the percentage of CD38+HLA-DR+ fraction among CD8+ T cells was higher in the patients with fatal outcomes compared with the surviving patients (37). This evidence concerns the gene CD8A and Hypertension.